Avid Bioservices Inc Receivables Turnover Ratio (CDMO), from the second quarter 2025 to the second quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Avid Bioservices Inc   (NASDAQ: CDMO)
 

Avid Bioservices Inc Accounts Receivables Turnover Ratio from the second quarter 2025 to the second quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Avid Bioservices Inc 's ability to collect accounts receivable sequentially worsen to 8.08, indicating more challenging environment then in the first quarter 2025, but still, it is a far cry from any concerns. Average collection period, for Avid Bioservices Inc 's accounts receivable remained unchanged at 45 days, in the Oct 31 2024 quarter.

If we take a look into Healthcare sector 330 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Oct 31 2024 from 1460 to 2274.

What is Receivable Turnover Ratio?
What is Avid Bioservices Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CDMO Receivables Turnover Ratio (Oct 31 2024)
II. Quarter		 (Jul 31 2024)
I. Quarter		 (Apr 30 2024)
IV. Quarter		 (Jan 31 2024)
III. Quarter		 (Oct 31 2023)
II. Quarter
Y / Y Receivable Change 37.61 % 29.32 % -9.04 % 25.04 % -34.99 %
Y / Y Revenue Change 32.16 % 8.28 % 11.5 % -12.19 % -27.11 %
Receivable Turnover Ratio (TTM) 8.08 8.19 8.6 8.12 8.9
CDMO's Total Ranking # 2274 # 1460 # 2264 # 2653 # 2658
Accounts Receivable average collection period days 45 45 42 45 41
Seq. Receivable Change -12.17 % 25.94 % -10.22 % 38.56 % -17.46 %
Seq. Revenue Change -16.66 % -7.65 % 30.31 % 31.77 % -31.71 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 91
Healthcare Sector # 331
Overall Market # 2274

Receivable Turnover Ratio Statistics
High Average Low
0.72 0.46 0.26
(Jul 31 2017)   (Oct 31 2014)





CDMO Company Profile • Back to CDMO Efficiency Comparisons • Compare CDMO Receivables Turnover Ratio to its Competitors

Financial Statements
Avid Bioservices Inc 's Accounts Receivable $ 18 Millions Visit CDMO's Balance sheet
Avid Bioservices Inc 's Sales TTM $ 151 Millions Visit CDMO's Income Statement
Sources of CDMO's Revenues Visit CDMO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CDMO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CDMO's Growth Rates CDMO's Roa CDMO's Inventory Turnover Ratio CDMO's Dividend Comparisons
CDMO's Profitability Ratios CDMO's Roi CDMO's Asset Turnover Ratio CDMO's Dividend Growth
CDMO's Valuation Ratios CDMO's Roe CDMO's Financial Strength Ratios CDMO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Oct 31 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Oct 31 2024 Receivable at quarter ending Oct 31 2024
U S Physical Therapy Inc  22.39 $ 645.699  Millions$ 28.841  Millions
Bespoke Extracts Inc  22.31 $ 1.080  Millions$ 0.048  Millions
Cytomx Therapeutics Inc   22.28 $ 126.617  Millions$ 5.684  Millions
One World Products Inc   22.21 $ 0.003  Millions$ 0.000  Millions
Igc Pharma Inc   21.71 $ 1.183  Millions$ 0.054  Millions
Innovative Eyewear Inc   21.65 $ 1.562  Millions$ 0.072  Millions
Ethema Health Corporation   21.31 $ 5.675  Millions$ 0.266  Millions
Generation Bio Co   20.94 $ 18.582  Millions$ 0.887  Millions
Innovage Holding Corp   20.21 $ 786.512  Millions$ 38.911  Millions
Co diagnostics Inc   19.94 $ 7.321  Millions$ 0.367  Millions
Nutriband Inc   19.66 $ 2.022  Millions$ 0.103  Millions
Innoviva Inc   19.25 $ 413.572  Millions$ 21.480  Millions
Kiniksa Pharmaceuticals International Plc  18.60 $ 384.098  Millions$ 20.650  Millions
Pulmatrix Inc   18.56 $ 10.005  Millions$ 0.539  Millions
Milestone Scientific Inc   18.54 $ 8.862  Millions$ 0.478  Millions
Hookipa Pharma inc   17.97 $ 49.999  Millions$ 2.782  Millions
Macrogenics Inc   17.38 $ 141.329  Millions$ 8.132  Millions
Zomedica Corp   17.34 $ 25.965  Millions$ 1.497  Millions
Talkspace Inc   16.98 $ 179.853  Millions$ 10.591  Millions
Medinotec Inc   16.59 $ 7.309  Millions$ 0.441  Millions
Scorpius Holdings inc   16.51 $ 10.044  Millions$ 0.608  Millions
Sangamo Therapeutics Inc   16.48 $ 52.291  Millions$ 3.173  Millions
Stablecoin Development Corporation  16.33 $ 11.199  Millions$ 0.686  Millions
Nexalin Technology Inc   16.24 $ 0.162  Millions$ 0.010  Millions
Inmed Pharmaceuticals Inc  16.11 $ 4.284  Millions$ 0.266  Millions
Precipio inc   16.07 $ 17.411  Millions$ 1.084  Millions
Fortress Biotech Inc   15.68 $ 62.501  Millions$ 3.986  Millions
Icu Medical Inc  14.80 $ 2,340.754  Millions$ 158.125  Millions
Biofrontera Inc   14.40 $ 61.432  Millions$ 4.265  Millions
Bgm Group Ltd  14.36 $ 24.115  Millions$ 1.679  Millions

Date modified: 2026-10-07T00:41:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.